US natural gas: a long-term bull market

published 22 August 2014

US natural gas prices have hovered around the $4 per million British thermal units (mbtu) mark for the past few years now. They've slipped back in recent months summer demand for air conditioning was lower than usual, while supply grew by 4% compared to last year, as producers pumped out more gas.

But in the long-term, expect prices to rise. Hydraulic fracturing (fracking') technology has made it possible to extract gas from once-inaccessible rock formations, giving supplies a huge boost. But demand should gradually catch up.

Fossil fuels are set to dominate the energy market for years to come, accounting for 75% of global energy supply in 2035, according to the International Energy Agency. Gas should gain most from this trend.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

It is the cleanest-burning fossil fuel, and today's low prices should encourage households and industries to switch to it, spurred partly by more stringent environmental regulations. There is a growing market for natural gas-powered vehicles, which currently account for around 1% of cars in the US.

There is also plenty of scope for the US to export more natural gas to parts of the world where gas is more expensive. Capital Economics reckons prices will have risen to $6 per mbtu by the end of 2016.

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.